PAA 0.00% 19.5¢ pharmaust limited

Ann: Final Ethics Approval for Open-Label MND Extension Study, page-9

  1. 5,766 Posts.
    lightbulb Created with Sketch. 1772
    Small group, but not small enough that the results can simply be ignored by sufferers, the wider medical community, and regulatory bodies. Months and months of treatment and no side effects and an apparent delay of symptoms at worst. Sometimes, it beggars belief that a life extending treatment cannot be fast tracked and widened out to a community, where currently, there is only one horrible, short term outcome.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.55M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.